Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
Alvarez-Lajonchere L, Shoukry NH, Grá B, Amador-Cañizares Y, Helle F, Bédard N, Guerra I, Drouin C, Dubuisson J, González-Horta EE, Martínez G, Marante J, Cinza Z, Castellanos M, Dueñas-Carrera S.
Alvarez-Lajonchere L, et al.
J Viral Hepat. 2009 Mar;16(3):156-67. doi: 10.1111/j.1365-2893.2008.01058.x. Epub 2008 Oct 31.
J Viral Hepat. 2009.
PMID: 19017255
Clinical Trial.